RENUKA. A et al. 2017. A randomised open label parallel group study on evaluation of efficacy and safety of gemifloxacin versus cefpodoxime in chronic obstructive pulmonary disease patients. International Journal of Pharma and Bio Sciences. 8, 2 (Jun. 2017), 324–331. DOI:https://doi.org/10.22376/ijpbs.2017.8.2.p324-331.